Translate Autumn - Winter 2016/2017 | Page 3

By Ade Oluwasanmi (PhD student in the Keele Nanopharmaceutics Research Group , Institute for Science & Technology in Medicine, Keele University) Medicine at the small scale The exponential growth in nanopharmaceutics Nanotechnology is the engineering of extremely small particulates with a wide variety of applications. Nanopharmaceutics is a form of nanotechnology that involves the formulation of medicines into very small doses suitable for administration through various routes, such as, intravenously for example (nanomedicine). Often drug molecules have undesirable properties: For example, drugs may not be very soluble in water or they may not be absorbed well by the body, which hinders their usage. These drugs require careful formulation in order for them to be administered to patients effectively and display their proposed therapeutic effect. Traditional formulation strategies do not live up to the growing demands of recent years where approximately 60% of all new drugs under development are classed as practically insoluble in water. Inevitably there has been an increase in nanomedicine research worldwide. The most common nano-systems for drug formulation are core-shell based systems. Many of these systems have undergone the rigors of regulatory testing and are now licensed for use in the clinic across the globe. The nano-structures act as chaperones for the drug molecules, carrying their cargo past the body’s defence systems and on to their intended target site, thus avoiding any premature drug degradation or metabolism. The nano-carriers themselves are relatively simple and cheap to make and they can be easily tailored for application. This tailoring may include the inclusion of specific functional groups which help the particles reach their destination more easily or confer additional properties, such as fluorescence in order for their journey after administration to be tracked. Nanopharmaceutics research has experienced exponential growth internationally in the past ten years. Here at ISTM we have a highly motivated and interdisciplinary Nanopharmaceutics team who strive to drive forward innovation in this area. Our area of research spans across the boundaries of chemistry, physics and the life sciences with an aim to produce novel nanomedicines for a wide variety of diseases. “ Our area of research spans across the boundaries of chemistry, physics and the life sciences with an aim to produce novel nanomedicines. NANOPHARMACEUTICS 2